Risk Factors for Tibial Plafond Nonunion: Medial Column Fixation May Reduce Nonunion Rates.


Journal

Journal of orthopaedic trauma
ISSN: 1531-2291
Titre abrégé: J Orthop Trauma
Pays: United States
ID NLM: 8807705

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 17 5 2019
medline: 21 10 2020
entrez: 17 5 2019
Statut: ppublish

Résumé

To identify the incidence and risk factors for development of tibial plafond nonunion. Retrospective comparative study. Two Level 1 academic trauma centers. Seven hundred forty tibial plafond fractures (OTA/AO 43B3 and 43C) treated January 2006 to December 2015. Open reduction and internal fixation. Nonunion. Five hundred eighteen patients with a mean age of 43 years (range, 18-81 years) and mean follow-up of 27 months (range, 12-115 months) were involved. Seventy-two patients (72/518, 14%) were identified as having a nonunion. Surgical approach was not associated with nonunion in univariate analysis. Multiple regression model 1 identified OTA/AO 43C [odds ratio (OR) = 4.43; 95% confidence interval (CI), 1.01-19.41; P = 0.048], tobacco use (OR = 2.02; 95% CI, 1.10-3.71; P = 0.024), both minimal and substantial bone loss (P = 0.006 and P < 0.001, respectively), and open fracture (OR = 1.96; 95% CI, 1.10-3.48; P = 0.022) as risk factors for tibial plafond nonunion. Model 2 identified locking plate (OR = 1.97; 95% CI, 1.13-3.40; P = 0.016) and failure to treat the medial column (vs. screw P = 0.047, or plate P = 0.038) as risk factors. The tibial plafond nonunion rate was 14%. Bone loss, open fracture, failure to treat the medial column, locking plates, and tobacco use were all significant risk factors for developing tibial plafond nonunion. Equally important, surgical approach was not significantly associated with plafond nonunion. Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Identifiants

pubmed: 31094937
doi: 10.1097/BOT.0000000000001500
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

443-449

Auteurs

Justin M Haller (JM)

Department of Orthopaedic Surgery, University of Utah School of Medicine, Salt Lake City, UT.

Michael Githens (M)

Department of Orthopedic Surgery, Harborview Medical Center, University of Washington, Seattle, WA.

David Rothberg (D)

Department of Orthopaedic Surgery, University of Utah School of Medicine, Salt Lake City, UT.

Thomas Higgins (T)

Department of Orthopaedic Surgery, University of Utah School of Medicine, Salt Lake City, UT.

Sean Nork (S)

Department of Orthopedic Surgery, Harborview Medical Center, University of Washington, Seattle, WA.

David Barei (D)

Department of Orthopedic Surgery, Harborview Medical Center, University of Washington, Seattle, WA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH